Anthropic’s confidential IPO filing in June 2026, followed by plans to release its prospectus shortly after Labor Day and target a late-September or early-October listing, has anchored trader consensus that the company will remain independent through 2026. The lab’s $65 billion Series H round at a $965 billion valuation, surging $47 billion revenue run-rate, and ongoing infrastructure deals underscore its ability to scale Claude without a strategic sale. While a surprise takeover bid from a hyperscaler remains theoretically possible amid fast-moving AI consolidation, the near-term public-market path, enterprise momentum, and scale make any acquisition before 2027 highly unlikely under current conditions.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว$29,748 ปริมาณ
$29,748 ปริมาณ
$29,748 ปริมาณ
$29,748 ปริมาณ
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
ตลาดเปิดเมื่อ: Nov 12, 2025, 5:14 PM ET
ผู้ตัดสินผล
0x65070BE91...Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
ผู้ตัดสินผล
0x65070BE91...Anthropic’s confidential IPO filing in June 2026, followed by plans to release its prospectus shortly after Labor Day and target a late-September or early-October listing, has anchored trader consensus that the company will remain independent through 2026. The lab’s $65 billion Series H round at a $965 billion valuation, surging $47 billion revenue run-rate, and ongoing infrastructure deals underscore its ability to scale Claude without a strategic sale. While a surprise takeover bid from a hyperscaler remains theoretically possible amid fast-moving AI consolidation, the near-term public-market path, enterprise momentum, and scale make any acquisition before 2027 highly unlikely under current conditions.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว



ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย